Advanced in Erythema Nodosum

Gerard Espinosa-Garriga

Barcelona, CT, ES 
Advanced in Erythema Nodosum
Barcelona, CT, ES 
OverviewLocationsClinical Research

Overview

Gerard Espinosa-Garriga practices in Barcelona, Spain. Mr. Espinosa-Garriga is rated as an Advanced expert by MediFind in the treatment of Erythema Nodosum. His top areas of expertise are Antiphospholipid Syndrome, Behcet Disease, Uveitis, Kidney Transplant, and Vitrectomy.

His clinical research consists of co-authoring 303 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Erythema Nodosum.

Gender
Male

Locations

Barcelona, CT, Spain
Other Locations
Pi, CT 08036, Spain
Sevilla, AN, Spain
Bellaterra, CT 08193, Spain
Las Palmas De Gran Canaria, CN, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Completed
Publish Date: November 23, 2022
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
View 1 Less Clinical Trial

303 Total Publications

Prediction model for renal outcomes in Latin American Mestizo patients with pure proliferative lupus nephritis.
Prediction model for renal outcomes in Latin American Mestizo patients with pure proliferative lupus nephritis.
Journal: Lupus science & medicine
Published: April 29, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Espinosa-Garriga's expertise for a condition
ConditionClose
View All 15 Advanced Conditions
View All 69 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile